Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:31 p.m.

    📋 Morphic Holding, Inc. (MORF) - Financial Results

    Filing Date: 2022-08-03

    Accepted: 2022-08-03 08:05:55

    Event Type: Financial Results

    Event Details:

    Morphic Therapeutic (MORF) Reports Q3 2022 Financial Results Morphic Therapeutic (MORF) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 60236
    • Net Income: 0.68
    • EPS: Not disclosed
    • Cash and equivalents: 397560
      • expected in the first half of 2025

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Other Income Total Other Income Expense -7.00 12.00 $-19.00 -158.33%
    Assets Cash Equivalents Marketable Securities 397.56K 397.56K $0.00 +0.00%
    Assets Other Assets 7.26K 7.96K $-700.00 -8.80%
    Revenue 60.24K 60.24K $0.00 +0.00%
    Loss from Operations 26.35K -27.84K $54.19K +194.64%
    Interest Income 482.00 35.00 $447.00 +1277.14%
    Other Income, Net 493.00 28.00 $465.00 +1660.71%
    Cash and Marketable Securities 397.56K 397.56K $0.00 +0.00%
    Other Assets 7.26K 7.96K $-700.00 -8.80%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Morphic Therapeutic
    • CIK: 0001679363
    • Ticker Symbol: MORF
    • Period End Date: 2022-08-03
    • Document Type: 8-K

Search

News categories